Brenton Rose

Title(s)Associate Professor Of Clinical, Radiation Medicine and Applied Science
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Neighborhood Deprivation, Race and Ethnicity, and Prostate Cancer Outcomes Across California Health Care Systems. JAMA Netw Open. 2024 Mar 04; 7(3):e242852. Wadhwa A, Roscoe C, Duran EA, Kwan L, Haroldsen CL, Shelton JB, Cullen J, Knudsen BS, Rettig MB, Pyarajan S, Nickols NG, Maxwell KN, Yamoah K, Rose BS, Rebbeck TR, Iyer HS, Garraway IP. PMID: 38502125; PMCID: PMC10951732.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Adrenal-Permissive Germline HSD3B1 Allele and Prostate Cancer Outcomes. JAMA Netw Open. 2024 Mar 04; 7(3):e242976. McKay RR, Nelson TJ, Pagadala MS, Teerlink CC, Gao A, Bryant AK, Agiri FY, Guram K, Thompson RF, Pridgen KM, Seibert TM, Lee KM, Carter H, Lynch JA, Hauger RL, Rose BS. PMID: 38506808; PMCID: PMC10955379.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. The incidence, pathogenesis, and management of non-clear cell renal cell carcinoma. Ther Adv Urol. 2024 Jan-Dec; 16:17562872241232578. Naik P, Dudipala H, Chen YW, Rose B, Bagrodia A, McKay RR. PMID: 38434237; PMCID: PMC10906063.
      View in: PubMed   Mentions:
    4. The Role of Radical Cystectomy in Clinically Node Positive Bladder Cancer: A US Veterans Health Administration Study. Clin Genitourin Cancer. 2024 Feb 15; 102055. Meagher M, Morgan KM, Deshler L, Puri D, Yuen K, Bagrodia A, Rose B, Stewart T, Salmasi A. PMID: 38458889.
      View in: PubMed   Mentions:    Fields:    
    5. Prostate Cancer Screening Uptake in Transgender Women. JAMA Netw Open. 2024 Feb 05; 7(2):e2356088. Kalavacherla S, Riviere P, Kalavacherla S, Anger JT, Murphy JD, Rose BS. PMID: 38353948; PMCID: PMC10867675.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Comparison of outcomes for Hispanic and non-Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database. Cancer. 2024 Jan 31. Guram K, Huang J, Mouchati C, Abdallah N, Jani C, Navani V, Xie W, El Zarif T, Adib E, Gebrael G, Agarwal N, Li H, Labaki C, Labban M, Ruiz Morales JM, Choueiri TK, Chin Heng DY, Mittal A, Hansen AR, Rose BS, McKay RR. PMID: 38297953.
      View in: PubMed   Mentions:    Fields:    
    7. An NLP Framework for the Extraction of Concept Measurements from Radiology and Pathology Notes. Stud Health Technol Inform. 2024 Jan 25; 310:1446-1447. Bowles A, Perez C, Vachani A, Steltz J, Rose B, Bryant AK, Eyre H, DuVall SL, Lynch JA, Alba PR. PMID: 38269689.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Genetic risk and likelihood of prostate cancer detection on first biopsy by ancestry. J Natl Cancer Inst. 2024 Jan 11. Lee KM, Nelson T, Bryant A, Teerlink C, Gulati R, Pagadala M, Tcheandjieu C, Pridgen KM, DuVall SL, Yamoah K, Vassy JL, Seibert TM, Hauger R, Rose BS, Lynch JA. PMID: 38212986.
      View in: PubMed   Mentions:    Fields:    
    9. Treatment Landscape of Renal Cell Carcinoma. Curr Treat Options Oncol. 2023 Dec; 24(12):1889-1916. Chen YW, Wang L, Panian J, Dhanji S, Derweesh I, Rose B, Bagrodia A, McKay RR. PMID: 38153686; PMCID: PMC10781877.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Comparison of Capture Rates of the National Cancer Database Across Race and Ethnicity. JAMA Netw Open. 2023 Dec 01; 6(12):e2350237. Satpathy Y, Nam P, Moldovan M, Murphy JD, Wang L, Derweesh I, Rose BS, Javier-DesLoges J. PMID: 38150248; PMCID: PMC10753391.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Opioid Tapering in Older Cancer Survivors Does Not Increase Psychiatric or Drug Hospitalization Rates. J Natl Cancer Inst. 2023 Nov 16. Riviere P, Morgan KM, Deshler LN, Huang X, Marienfeld C, Coyne CJ, Rose BS, Murphy JD. PMID: 37971959.
      View in: PubMed   Mentions:    Fields:    
    12. Association between prediagnostic prostate-specific antigen and prostate cancer probability in Black and non-Hispanic White men. Cancer. 2024 01; 130(2):224-231. Lee KM, Bryant AK, Lynch JA, Robison B, Alba PR, Agiri FY, Pridgen KM, DuVall SL, Yamoah K, Garraway IP, Rose BS. PMID: 37927109.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    13. Outcomes of Patients With Advanced Renal Cell Carcinoma With Non-Clear Cell Histology Treated With Systemic Therapy. Clin Genitourin Cancer. 2023 Dec; 21(6):660-668.e1. Urman D, Deshler L, Weise N, Shabaik A, Derweesh I, Bagrodia A, Rose B, Herchenhorn D, McKay RR. PMID: 37858374.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Actionable Genomic Alterations in Prostate Cancer Among Black and White United States Veterans. Oncologist. 2023 06 02; 28(6):e473-e477. Valle LF, Nickols NG, Hausler R, Alba PR, Anglin-Foote T, Perez C, Yamoah K, Rose BS, Kelley MJ, DuVall SL, Garraway IP, Maxwell KN, Lynch JA. PMID: 37084789; PMCID: PMC10243786.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    15. Transoral Surgery in HPV-Positive Oropharyngeal Carcinoma: Oncologic Outcomes in the Veterans Affairs System. Laryngoscope. 2024 Jan; 134(1):207-214. Faraji F, Kumar A, Voora R, Soliman SI, Cherry D, Courtney PT, Finegersh A, Guo T, Cohen E, Califano JA, Mell L, Rose B, Orosco RK. PMID: 37255050; PMCID: PMC10687307.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Low-Value Prostate-Specific Antigen Screening in Older Males. JAMA Netw Open. 2023 04 03; 6(4):e237504. Kalavacherla S, Riviere P, Javier-DesLoges J, Banegas MP, McKay RR, Murphy JD, Rose BS. PMID: 37040113; PMCID: PMC10091155.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    17. Associations Between Intraductal Prostate Cancer and Metastases Following Radical Prostatectomy in Men With Prostate Cancer in the Veterans Affairs Database. Clin Genitourin Cancer. 2023 08; 21(4):452-458. Nelson TJ, Kumar A, Nalawade V, Nonato T, Shabaik A, Roma A, Rose BS, McKay RR. PMID: 37095044.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Response to Haiman, Kote-Jarai, Darst et al. J Natl Cancer Inst. 2023 03 09; 115(3):343-344. Seibert TM, Pagadala MS, Lynch J, Karunamuni R, Carter H, Rose BS, Hauger RL. PMID: 36629482; PMCID: PMC9996213.
      View in: PubMed   Mentions:    Fields:    
    19. Prognostic Value of the Intermediate-risk Feature in Men with Favorable Intermediate-risk Prostate Cancer: Implications for Active Surveillance. Eur Urol Open Sci. 2023 Apr; 50:61-67. Sherer MV, Leonard AJ, Nelson TJ, Courtney PT, Guram K, Rodrigues De Moraes G, Javier-Desloges J, Kane C, McKay RR, Rose BS, Bagrodia A. PMID: 37101776; PMCID: PMC10123417.
      View in: PubMed   Mentions: 1  
    20. Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program. J Natl Cancer Inst. 2023 02 08; 115(2):190-199. Pagadala MS, Lynch J, Karunamuni R, Alba PR, Lee KM, Agiri FY, Anglin T, Carter H, Gaziano JM, Jasuja GK, Deka R, Rose BS, Panizzon MS, Hauger RL, Seibert TM. PMID: 36305680; PMCID: PMC9905969.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    21. Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial. Eur Urol. 2024 Apr; 85(4):373-381. Mell LK, Pugh SL, Jones CU, Nelson TJ, Zakeri K, Rose BS, Zeitzer KL, Gore EM, Bahary JP, Souhami L, Michalski JM, Hartford AC, Mishra MV, Roach M, Parliament MB, Choi KN, Pisansky TM, Husain SM, Malone SC, Horwitz EM, Feng F. PMID: 36710205; PMCID: PMC10372191.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. The Current and Future Promises of Combination Radiation and Immunotherapy for Genitourinary Cancers. Cancers (Basel). 2022 Dec 25; 15(1). Saidian A, Dolendo I, Sharabi A, Stewart TF, Rose B, McKay RR, Bagrodia A, Salmasi A. PMID: 36612124; PMCID: PMC9818005.
      View in: PubMed   Mentions: 2  
    23. Functional outcomes after prostate cancer treatment: A comparison between single and multiple modalities. Urol Oncol. 2023 02; 41(2):104.e1-104.e9. Muise A, Pan MM, Rose B, Buckley JC. PMID: 36535862.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    24. PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry. BMC Cancer. 2022 Dec 09; 22(1):1289. Pagadala MS, Linscott JA, Talwar JV, Seibert TM, Rose B, Lynch J, Panizzon M, Hauger R, Hansen MH, Sammon JD, Hayn MH, Kader K, Carter H, Ryan ST. PMID: 36494783; PMCID: PMC9733391.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities. JAMA Oncol. 2022 12 01; 8(12):1747-1755. Bryant AK, Lee KM, Alba PR, Murphy JD, Martinez ME, Natarajan L, Green MD, Dess RT, Anglin-Foote TR, Robison B, DuVall SL, Lynch JA, Rose BS. PMID: 36279204; PMCID: PMC9593319.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    26. Differential regulation of TNFα and IL-6 expression contributes to immune evasion in prostate cancer. J Transl Med. 2022 11 12; 20(1):527. Deichaite I, Sears TJ, Sutton L, Rebibo D, Morgan K, Nelson T, Rose B, Tamayo P, Ferrara N, Asimakopoulos F, Carter H. PMID: 36371231; PMCID: PMC9652804.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    27. Patient perspectives of prostate cancer screening vary by race following 2018 guideline changes. Cancer. 2023 01 01; 129(1):82-88. Riviere P, Kalavacherla S, Banegas MP, Javier-Desloges J, Martinez ME, Garraway IP, Murphy JD, Rose BS. PMID: 36345568.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    28. Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol Oncol. 2023 04; 6(2):204-211. Loo Gan C, Huang J, Pan E, Xie W, Schmidt AL, Labaki C, Meza L, Bouchard G, Li H, Jackson-Spence F, Sánchez-Ruiz C, Powles T, Kumar SA, Weise N, Hall WA, Rose BS, Beuselinck B, Suarez C, Pal SK, Choueiri TK, Heng DYC, McKay RR. PMID: 36328934.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    29. Association Between Primary Care Use Prior to Cancer Diagnosis and Subsequent Cancer Mortality in the Veterans Affairs Health System. JAMA Netw Open. 2022 11 01; 5(11):e2242048. Qiao EM, Guram K, Kotha NV, Voora RS, Qian AS, Ahn GS, Kalavacherla S, Pindus R, Banegas MP, Stewart TF, Johnson ML, Murphy JD, Rose BS. PMID: 36374497; PMCID: PMC9664263.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Examining the Effect of Direct Patient Care for Medical Physicists: A Randomized Prospective Phase III Trial. Int J Radiat Oncol Biol Phys. 2023 01 01; 115(1):224-232. Atwood TF, Brown DW, Murphy JD, Moore KL, Juang T, Azuara A, Mayadev JS, Rose BS, Sandhu AP, Mundt AJ, Pawlicki T. PMID: 36289039.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    31. Association Between Prostate-Specific Antigen Screening and Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White US Veterans. JAMA Oncol. 2022 10 01; 8(10):1471-1476. Sherer MV, Qiao EM, Kotha NV, Qian AS, Rose BS. PMID: 35925581; PMCID: PMC9353702.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    32. Correction: Germline alterations among Hispanic men with prostate cancer. Prostate Cancer Prostatic Dis. 2022 Sep; 25(3):599. Pan E, Shaya J, Madlensky L, Randall JM, Javier-Desloges J, Millard FE, Rose B, Parsons JK, Nielsen SM, Hatchell KE, Esplin ED, Nussbaum RL, Weise N, Murphy J, Martinez ME, McKay RR. PMID: 35488122.
      View in: PubMed   Mentions:    Fields:    
    33. Impact of COVID-19 on the incidence of localized and metastatic prostate cancer among White and Black Veterans. Cancer Med. 2023 02; 12(3):3727-3730. Lee KM, Bryant AK, Alba P, Anglin T, Robison B, Rose BS, Lynch JA. PMID: 35984395; PMCID: PMC9538539.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    34. The Prognostic Significance of Homologous Recombination Repair Pathway Alterations in Metastatic Hormone Sensitive Prostate Cancer. Clin Genitourin Cancer. 2022 12; 20(6):515-523. Lee AM, Saidian A, Shaya J, Nonato T, Cabal A, Randall JM, Millard F, Stewart T, Rose B, Tamayo P, McKay RR. PMID: 35871039; PMCID: PMC10257153.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    35. An evaluation of trends in the representation of patients by age, sex, and diverse race/ethnic groups in bladder and kidney cancer clinical trials. Urol Oncol. 2022 05; 40(5):199.e15-199.e21. Javier-DesLoges J, Nelson TJ, Murphy JD, McKay RR, Stewart TF, Kader AK, Derweesh I, Martinez ME, Rose BS. PMID: 35431133; PMCID: PMC10441556.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    36. Evaluating Prostate-Specific Antigen Screening for Young African American Men With Cancer. J Natl Cancer Inst. 2022 04 11; 114(4):592-599. Qiao EM, Lynch JA, Lee KM, Kotha NV, Nalawade V, Voora RS, Qian AS, Nelson TJ, Yamoah K, Garraway IP, Stewart TF, Parsons JK, Rose BS. PMID: 34893859; PMCID: PMC9002290.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    37. Association of Health-Care System and Survival in African American and Non-Hispanic White Patients With Bladder Cancer. J Natl Cancer Inst. 2022 04 11; 114(4):600-608. Kotha NV, Kumar A, Qiao EM, Qian AS, Voora RS, Nalawade V, Karim Kader A, McKay RR, Stewart TF, Rose BS. PMID: 34918091; PMCID: PMC9002275.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Germline alterations among Hispanic men with prostate cancer. Prostate Cancer Prostatic Dis. 2022 09; 25(3):561-567. Pan E, Shaya J, Madlensky L, Randall JM, Javier-Desloges J, Millard FE, Rose B, Parsons JK, Nielsen SM, Hatchell KE, Esplin ED, Nussbaum RL, Weise N, Murphy J, Martinez ME, McKay RR. PMID: 35228665.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    39. Outcomes by time to definitive chemoradiation treatment for patients with muscle-invasive bladder cancer. Urol Oncol. 2022 06; 40(6):274.e1-274.e6. Kotha NV, Kumar A, Nelson TJ, Qiao EM, Qian AS, Voora RS, McKay RR, Rose BS, Stewart TF. PMID: 35216893; PMCID: PMC8863428.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    40. Metastasis and Mortality in Men With Low- and Intermediate-Risk Prostate Cancer on Active Surveillance. J Natl Compr Canc Netw. 2022 02; 20(2):151-159. Courtney PT, Deka R, Kotha NV, Cherry DR, Salans MA, Nelson TJ, Kumar A, Luterstein E, Yip AT, Nalawade V, Parsons JK, Kader AK, Stewart TF, Rose BS. PMID: 35130495; PMCID: PMC10399925.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    41. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System. JAMA Netw Open. 2022 01 04; 5(1):e2144027. Yamoah K, Lee KM, Awasthi S, Alba PR, Perez C, Anglin-Foote TR, Robison B, Gao A, DuVall SL, Katsoulakis E, Wong YN, Markt SC, Rose BS, Burri R, Wang C, Aboiralor O, Fink AK, Nickols NG, Lynch JA, Garraway IP. PMID: 35040965; PMCID: PMC8767437.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    42. Impact of age on treatment response in men with prostate cancer treated with radiotherapy. BJUI Compass. 2022 May; 3(3):243-250. Bryant AK, Nelson TJ, McKay RR, Kader AK, Parsons JK, Einck JP, Kane CJ, Sandhu AP, Mundt AJ, Murphy JD, Rose BS. PMID: 35492227; PMCID: PMC9045578.
      View in: PubMed   Mentions: 2  
    43. Analysis of CDK12 alterations in a pan-cancer database. Cancer Med. 2022 02; 11(3):753-763. Pan E, Cabal A, Javier-DesLoges J, Patel D, Panian J, Lee S, Shaya J, Nonato T, Xu X, Stewart T, Rose B, Shabaik A, Cohen E, Kurzrock R, Tamayo P, McKay RR. PMID: 34898046; PMCID: PMC8817093.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    44. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials. Cancer. 2022 02 15; 128(4):770-777. Javier-DesLoges J, Nelson TJ, Murphy JD, McKay RR, Pan E, Parsons JK, Kane CJ, Kader AK, Derweesh IH, Nodora J, Patel SP, Martinez ME, Rose BS. PMID: 34806168.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    45. Androgen deprivation therapy and acute kidney injury in patients with prostate cancer undergoing definitive radiotherapy. Prostate Cancer Prostatic Dis. 2023 06; 26(2):276-281. Sherer MV, Deka R, Salans MA, Nelson TJ, Sheridan P, Rose BS. PMID: 34811501.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    46. Treatment Discontinuation in Patients With Muscle-Invasive Bladder Cancer Undergoing Chemoradiation. Adv Radiat Oncol. 2022 Jan-Feb; 7(1):100836. Kotha NV, Kumar A, Nelson TJ, Qiao EM, Qian AS, Voora RS, McKay RR, Stewart TF, Rose BS. PMID: 35071834; PMCID: PMC8767252.
      View in: PubMed   Mentions:
    47. Prognostic Utility of Pretreatment Neutrophil-Lymphocyte Ratio in Advanced Larynx Cancer. Biomark Insights. 2021; 16:11772719211049848. Kotha NV, Voora RS, Qian AS, Kumar A, Qiao EM, Stewart TF, Rose BS, Orosco RK. PMID: 34658619; PMCID: PMC8512256.
      View in: PubMed   Mentions: 3  
    48. Patterns of Failure After Definitive Treatment of T4a Larynx Cancer. Otolaryngol Head Neck Surg. 2022 08; 167(2):274-285. Voora RS, Panuganti BA, Flagg M, Nelson T, Kotha NV, Qiao EM, Qian AS, Kumar A, Stewart TF, Rose B, Califano J, Weissbrod PA, Mell LK, Orosco RK. PMID: 34609937.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    49. Association of Health-Care System With Prostate Cancer-Specific Mortality in African American and Non-Hispanic White Men. J Natl Cancer Inst. 2021 10 01; 113(10):1343-1351. Klebaner D, Courtney PT, Garraway IP, Einck J, Kumar A, Martinez ME, McKay R, Murphy JD, Parada H, Sandhu A, Stewart T, Yamoah K, Rose BS. PMID: 33892497; PMCID: PMC8486332.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    50. Evaluating the clinical trends and benefits of low-dose computed tomography in lung cancer patients. Cancer Med. 2021 10; 10(20):7289-7297. Qiao EM, Voora RS, Nalawade V, Kotha NV, Qian AS, Nelson TJ, Durkin M, Vitzthum LK, Murphy JD, Stewart TF, Rose BS. PMID: 34528761; PMCID: PMC8525167.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    51. Ascertainment of Veterans With Metastatic Prostate Cancer in Electronic Health Records: Demonstrating the Case for Natural Language Processing. JCO Clin Cancer Inform. 2021 09; 5:1005-1014. Alba PR, Gao A, Lee KM, Anglin-Foote T, Robison B, Katsoulakis E, Rose BS, Efimova O, Ferraro JP, Patterson OV, Shelton JB, Duvall SL, Lynch JA. PMID: 34570630.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    52. Prospects for daily online adaptive radiotherapy via ethos for prostate cancer patients without nodal involvement using unedited CBCT auto-segmentation. J Appl Clin Med Phys. 2021 Oct; 22(10):82-93. Moazzezi M, Rose B, Kisling K, Moore KL, Ray X. PMID: 34432932; PMCID: PMC8504605.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    53. Active surveillance for intermediate-risk prostate cancer in African American and non-Hispanic White men. Cancer. 2021 12 01; 127(23):4403-4412. Courtney PT, Deka R, Kotha NV, Cherry DR, Salans MA, Nelson TJ, Kumar A, Luterstein E, Yip AT, Nalawade V, Parsons JK, Kader AK, Stewart TF, Rose BS. PMID: 34347291.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    54. Salvage Following Transoral Laser Microsurgery for Early Glottic Cancer in National Veteran Database. Laryngoscope. 2021 12; 131(12):2766-2772. Voora RS, Panuganti B, Flagg M, Kumar A, Qian AS, Kotha NV, Qiao EM, Weissbrod PA, Rose B, Orosco RK. PMID: 34296772.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    55. Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24. Prostate Cancer Prostatic Dis. 2022 02; 25(2):229-237. Karunamuni RA, Huynh-Le MP, Fan CC, Thompson W, Lui A, Martinez ME, Rose BS, Mahal B, Eeles RA, Kote-Jarai Z, Muir K, Lophatananon A, UKGPCS Collaborators, Tangen CM, Goodman PJ, Thompson IM, Blot WJ, Zheng W, Kibel AS, Drake BF, Cussenot O, Cancel-Tassin G, Menegaux F, Truong T, Park JY, Lin HY, Taylor JA, Bensen JT, Mohler JL, Fontham ETH, Multigner L, Blanchet P, Brureau L, Romana M, Leach RJ, John EM, Fowke JH, Bush WS, Aldrich MC, Crawford DC, Cullen J, Petrovics G, Parent MÉ, Hu JJ, Sanderson M, PRACTICAL Consortium, Mills IG, Andreassen OA, Dale AM, Seibert TM. PMID: 34127801; PMCID: PMC8669040.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    56. Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans. Eur Urol Open Sci. 2021 Aug; 30:1-10. Kumar A, Cherry DR, Courtney PT, Nalawade V, Kotha N, Riviere PJ, Efstathiou J, McKay RR, Karim Kader A, Rose BS, Stewart TF. PMID: 34337540; PMCID: PMC8317783.
      View in: PubMed   Mentions: 7  
    57. Impact of Radiation on Cardiovascular Outcomes in Older Resectable Esophageal Cancer Patients With Medicare. Am J Clin Oncol. 2021 06 01; 44(6):275-282. Sarkar RR, Hatamipour A, Panjwani N, Courtney PT, Cherry DR, Salans MA, Yip AT, Rose BS, Simpson DR, Banegas MP, Murphy JD. PMID: 33782335; PMCID: PMC8141011.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    58. Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance. JAMA Netw Open. 2021 05 03; 4(5):e219452. Nelson TJ, Javier-DesLoges J, Deka R, Courtney PT, Nalawade V, Mell L, Murphy J, Parsons JK, Rose BS. PMID: 33999164; PMCID: PMC8129822.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    59. Prognostic utility of pretreatment neutrophil-lymphocyte ratio in survival outcomes in localized non-small cell lung cancer patients treated with stereotactic body radiotherapy: Selection of an ideal clinical cutoff point. Clin Transl Radiat Oncol. 2021 May; 28:133-140. Kotha NV, Cherry DR, Bryant AK, Nalawade V, Stewart TF, Rose BS. PMID: 33997320; PMCID: PMC8089768.
      View in: PubMed   Mentions: 3  
    60. Association of race and health care system with disease stage and survival in veterans with larynx cancer. Cancer. 2021 08 01; 127(15):2705-2713. Voora RS, Kotha NV, Kumar A, Qiao EM, Qian AS, Panuganti BA, Banegas MP, Weissbrod PA, Stewart TF, Rose BS, Orosco RK. PMID: 33799314.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    61. Validation of an oncology-specific opioid risk calculator in cancer survivors. Cancer. 2021 05 01; 127(9):1529-1535. Riviere P, Vitzthum LK, Nalawade V, Deka R, Furnish T, Mell LK, Rose BS, Wallace M, Murphy JD. PMID: 33378556.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    62. Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance. JAMA. 2020 11 03; 324(17):1747-1754. Deka R, Courtney PT, Parsons JK, Nelson TJ, Nalawade V, Luterstein E, Cherry DR, Simpson DR, Mundt AJ, Murphy JD, D'Amico AV, Kane CJ, Martinez ME, Rose BS. PMID: 33141207; PMCID: PMC7610194.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    63. Pathologic nodal downstaging in men with clinically involved lymph nodes undergoing radical prostatectomy: Implications for definitive locoregional therapy. Urol Oncol. 2021 02; 39(2):130.e1-130.e7. Ghali F, Daly WC, Hansen M, Hayn M, Sammon J, Beaule LT, Sarkar R, Murphy J, Kader AK, Derweesh I, Rose B, Ryan ST. PMID: 33121914.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    64. Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration. Cancer. 2021 02 01; 127(3):403-411. McKay RR, Sarkar RR, Kumar A, Einck JP, Garraway IP, Lynch JA, Mundt AJ, Murphy JD, Stewart TF, Yamoah K, Rose BS. PMID: 33036065.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    65. Stereotactic body radiotherapy versus conventional/moderate fractionated radiation therapy with androgen deprivation therapy for unfavorable risk prostate cancer. Radiat Oncol. 2020 Sep 15; 15(1):217. Patel SA, Switchenko JM, Fischer-Valuck B, Zhang C, Rose BS, Chen RC, Jani AB, Royce TJ. PMID: 32933541; PMCID: PMC7493337.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    66. Three-tiered Subclassification System of High-risk Prostate Cancer in Men Managed With Radical Prostatectomy: Implications for Treatment Decision-making. Urology. 2020 11; 145:197-203. Lamba N, Butler S, Mahal BA, Trinh QD, Rose B, King M, Orio P, Mouw KW, Martin N, Leeman JE, Feng FY, Nguyen PL, Muralidhar V. PMID: 32763323.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    67. Reply to Equal access to health care reduces racial disparities in prostate cancer outcomes and Access and socioeconomic status play an important role in outcomes for African American patients with prostate cancer. Cancer. 2020 09 15; 126(18):4258. Riviere PJ, Rose BS. PMID: 32644210.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    68. Evaluation of the Use of Cancer Registry Data for Comparative Effectiveness Research. JAMA Netw Open. 2020 07 01; 3(7):e2011985. Kumar A, Guss ZD, Courtney PT, Nalawade V, Sheridan P, Sarkar RR, Banegas MP, Rose BS, Xu R, Murphy JD. PMID: 32729921; PMCID: PMC9009816.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    69. Predicting Persistent Opioid Use, Abuse, and Toxicity Among Cancer Survivors. J Natl Cancer Inst. 2020 07 01; 112(7):720-727. Vitzthum LK, Riviere P, Sheridan P, Nalawade V, Deka R, Furnish T, Mell LK, Rose B, Wallace M, Murphy JD. PMID: 31754696; PMCID: PMC7357328.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    70. Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease. Prostate Cancer Prostatic Dis. 2020 12; 23(4):689-695. Sarkar RR, Patel SH, Parsons JK, Deka R, Kumar A, Einck JP, Mundt AJ, Kader AK, Kane CJ, Riviere P, McKay R, Murphy JD, Rose BS. PMID: 32513967.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    71. Palliative Radiotherapy Versus Esophageal Stent Placement in the Management of Patients With Metastatic Esophageal Cancer. J Natl Compr Canc Netw. 2020 05; 18(5):569-574. Martin EJ, Bruggeman AR, Nalawade VV, Sarkar RR, Qiao EM, Rose BS, Murphy JD. PMID: 32380466.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    72. African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance. Prostate Cancer Prostatic Dis. 2020 12; 23(4):581-588. Deka R, Parsons JK, Simpson DR, Riviere P, Nalawade V, Vitzthum LK, Kader AK, Kane CJ, Rock CS, Murphy JD, Rose BS. PMID: 32327702.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    73. Associations among statins, preventive care, and prostate cancer mortality. Prostate Cancer Prostatic Dis. 2020 09; 23(3):475-485. Kumar A, Riviere P, Luterstein E, Nalawade V, Vitzthum L, Sarkar RR, Bryant AK, Einck JP, Mundt AJ, Murphy JD, Rose BS. PMID: 32029930.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    74. Survival of African American and non-Hispanic white men with prostate cancer in an equal-access health care system. Cancer. 2020 04 15; 126(8):1683-1690. Riviere P, Luterstein E, Kumar A, Vitzthum LK, Deka R, Sarkar RR, Bryant AK, Bruggeman A, Einck JP, Murphy JD, Martínez ME, Rose BS. PMID: 31984482.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    75. Combined Androgen Blockade in Localized Prostate Cancer Treated With Definitive Radiation Therapy. J Natl Compr Canc Netw. 2019 12; 17(12):1497-1504. Vitzthum LK, Straka C, Sarkar RR, McKay R, Randall JM, Sandhu A, Murphy JD, Rose BS. PMID: 31805534.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    76. Tobacco smoking and death from prostate cancer in US veterans. Prostate Cancer Prostatic Dis. 2020 06; 23(2):252-259. Riviere P, Kumar A, Luterstein E, Vitzthum LK, Nalawade V, Sarkar RR, Bryant AK, Einck JP, Mundt AJ, Murphy JD, Rose BS. PMID: 31624316.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    77. Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults. JAMA Netw Open. 2019 10 02; 2(10):e1913612. Kumar A, Nalawade V, Riviere P, Sarkar RR, Parsons JK, Murphy JD, Rose BS. PMID: 31626312; PMCID: PMC6813580.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    78. Benefits of Targeted Use of 5α-Reductase Inhibitors in Patients With Prostate Cancer-Reply. JAMA Intern Med. 2019 10 01; 179(10):1442. Sarkar RR, Rose BS. PMID: 31589266.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    79. 5α-Reductase Inhibitor Use in Patients With Prostate Cancer-Reply. JAMA Intern Med. 2019 10 01; 179(10):1440-1441. Sarkar RR, Rose BS. PMID: 31589264.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    80. A Matched Case-Control Analysis of Clinical Outcomes for Patients With Inflammatory Bowel Disease and Rectal Cancer Treated With Pelvic Radiation Therapy. Int J Radiat Oncol Biol Phys. 2019 12 01; 105(5):994-1004. Mudgway R, Bryant AK, Heide ES, Riviere P, O'Hare C, Rose BS, Murphy JD, Simpson DR. PMID: 31461672.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    81. Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen Level. J Natl Compr Canc Netw. 2019 08 01; 17(8):941-948. Muralidhar V, Nguyen PL, Mahal BA, Yang DD, Mouw KW, Rose BS, Beard CJ, Efstathiou JA, Martin NE, King MT, Orio PF. PMID: 31390585.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    82. Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer. JAMA Intern Med. 2019 06 01; 179(6):812-819. Sarkar RR, Parsons JK, Bryant AK, Ryan ST, Kader AK, McKay RR, D'Amico AV, Nguyen PL, Hulley BJ, Einck JP, Mundt AJ, Kane CJ, Murphy JD, Rose BS. PMID: 31058923; PMCID: PMC6503564.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    83. In Reply to Hurmuz and Ozyigit. Int J Radiat Oncol Biol Phys. 2019 05 01; 104(1):225. Bryant AK, Rose BS. PMID: 30967234.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    84. Stroke and thromboembolic events in men with prostate cancer treated with definitive radiation therapy with or without androgen deprivation therapy. Prostate Cancer Prostatic Dis. 2019 12; 22(4):600-608. Deka R, Simpson DR, Panizzon MS, Hauger RL, Riviere P, Nalawade V, McKay R, Murphy JD, Rose BS. PMID: 30988408.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    85. Claims-Based Approach to Predict Cause-Specific Survival in Men With Prostate Cancer. JCO Clin Cancer Inform. 2019 03; 3:1-7. Riviere P, Tokeshi C, Hou J, Nalawade V, Sarkar R, Paravati AJ, Schiaffino M, Rose B, Xu R, Murphy JD. PMID: 30830794; PMCID: PMC6873997.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    86. Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy. Cancer. 2019 04 01; 125(7):1070-1080. Deka R, Rose BS, Bryant AK, Sarkar RR, Nalawade V, McKay R, Murphy JD, Simpson DR. PMID: 30748008.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    87. Postoperative radiation and hormonal therapy for men with node-positive prostate cancer: a new standard? BJU Int. 2019 02; 123(2):199-200. Rose BS. PMID: 30656836.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    88. Detecting a Survival Benefit to Dose Escalation. JAMA Oncol. 2019 01 01; 5(1):109-110. Zakeri K, Rose BS, Mell LK. PMID: 30452492.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    89. Subcastrate Testosterone Nadir and Clinical Outcomes in Intermediate- or High-Risk Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2019 04 01; 103(5):1068-1076. Bryant AK, McKay RR, Kader AK, Parsons JK, Einck JP, Kane CJ, Mundt AJ, Murphy JD, Rose BS. PMID: 30543857.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    90. Association of Androgen Deprivation Therapy With Dementia in Men With Prostate Cancer Who Receive Definitive Radiation Therapy. JAMA Oncol. 2018 11 01; 4(11):1616-1617. Deka R, Simpson DR, Bryant AK, Nalawade V, McKay R, Murphy JD, Rose BS. PMID: 30325986; PMCID: PMC6248075.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    91. Association between Radical Prostatectomy and Survival in Men with Clinically Node-positive Prostate Cancer. Eur Urol Oncol. 2019 09; 2(5):584-588. Sarkar RR, Bryant AK, Parsons JK, Ryan ST, Karim Kader A, Kane CJ, McKay RR, Sandhu A, Murphy JD, Rose BS. PMID: 31411995; PMCID: PMC6697241.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    92. Three-month posttreatment prostate-specific antigen level as a biomarker of treatment response in patients with intermediate-risk or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapy. Cancer. 2018 07 15; 124(14):2939-2947. Bryant AK, D'Amico AV, Nguyen PL, Einck JP, Kane CJ, McKay RR, Simpson DR, Mundt AJ, Murphy JD, Rose BS. PMID: 29727915.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    93. Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 08 01; 101(5):1188-1193. Bryant AK, Kader AK, McKay RR, Einck JP, Mell LK, Mundt AJ, Kane CJ, Efstathiou JA, Murphy JD, Rose BS. PMID: 29891203.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    94. Who benefits most from early salvage radiation therapy after prostatectomy? Transl Androl Urol. 2018 Mar; 7(Suppl 1):S124-S127. Nath SK, Rose BS, Pugh TJ. PMID: 29644179; PMCID: PMC5881213.
      View in: PubMed   Mentions:
    95. Salvage image guided radiation therapy to the prostate after cryotherapy failure. Adv Radiat Oncol. 2018 Jan-Mar; 3(1):52-56. Hopper AB, Sandhu APS, Parsons JK, Rose B, Einck JP. PMID: 29556580; PMCID: PMC5856984.
      View in: PubMed   Mentions: 5  
    96. Irradiation of anatomically defined pelvic subsites and acute hematologic toxicity in anal cancer patients undergoing chemoradiation. Pract Radiat Oncol. 2017 Sep - Oct; 7(5):e291-e297. Rose B, Mitra D, Hong TS, Jee KW, Niemierko A, Drapek LN, Blaszkowsky LS, Allen JN, Murphy JE, Clark JW, Ryan DP, Wo JY. PMID: 28462895.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    97. Reply to S. Sorscher. J Clin Oncol. 2017 05 20; 35(15):1746-1747. Rose BS, Winer EP, Mamon HJ. PMID: 28524778.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    98. Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529. Adv Radiat Oncol. 2017 Apr-Jun; 2(2):110-117. Mitra D, Hong TS, Horick N, Rose B, Drapek LN, Blaszkowsky LS, Allen JN, Kwak EL, Murphy JE, Clark JW, Ryan DP, Cusack JC, Bordeianou LG, Berger DL, Wo JY. PMID: 28740921; PMCID: PMC5514246.
      View in: PubMed   Mentions: 23  
    99. Perils of the Pathologic Complete Response. J Clin Oncol. 2016 11 20; 34(33):3959-3962. Rose BS, Winer EP, Mamon HJ. PMID: 27551115.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    100. Disparities in the Receipt of Local Treatment of Node-positive Prostate Cancer. Clin Genitourin Cancer. 2017 10; 15(5):563-569.e3. Muralidhar V, Mahal BA, Rose BS, Chen YW, Nezolosky MD, Efstathiou JA, Beard CJ, Martin NE, Orio PF, Trinh QD, Choueiri TK, Sweeney CJ, Nguyen PL. PMID: 28462857.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    101. Androgen Deprivation Therapy Use in the Setting of High-dose Radiation Therapy and the Risk of Prostate Cancer-Specific Mortality Stratified by the Extent of Competing Mortality. Int J Radiat Oncol Biol Phys. 2016 11 15; 96(4):778-784. Rose BS, Chen MH, Wu J, Braccioforte MH, Moran BJ, Doseretz DE, Katin MJ, Ross RH, Salenius SA, D'Amico AV. PMID: 27788950.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    102. Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice? Int J Radiat Oncol Biol Phys. 2016 10 01; 96(2):313-317. Muralidhar V, Rose BS, Chen YW, Nezolosky MD, Nguyen PL. PMID: 27496390.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    103. Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing Events. J Clin Oncol. 2016 Apr 10; 34(11):1270-7. Carmona R, Zakeri K, Green G, Hwang L, Gulaya S, Xu B, Verma R, Williamson CW, Triplett DP, Rose BS, Shen H, Vaida F, Murphy JD, Mell LK. PMID: 26884579; PMCID: PMC5070568.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    104. Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation. Int J Radiat Oncol Biol Phys. 2016 Mar 15; 94(4):747-54. Rose BS, Jee KW, Niemierko A, Murphy JE, Blaszkowsky LS, Allen JN, Lee LK, Wang Y, Drapek LC, Hong TS, Wo JY. PMID: 26972647.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    105. Effect of lymph node metastasis size on breast cancer-specific and overall survival in women with node-positive breast cancer. Breast Cancer Res Treat. 2015 Jul; 152(1):209-216. Rose BS, Jiang W, Punglia RS. PMID: 26041688.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    106. Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer. Radiother Oncol. 2015 Apr; 115(1):114-9. Zakeri K, Rose BS, D'Amico AV, Jeong JH, Mell LK. PMID: 25857696.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    107. Complications of pelvic radiation in patients treated for gynecologic malignancies. Cancer. 2014 Dec 15; 120(24):3870-83. Viswanathan AN, Lee LJ, Eswara JR, Horowitz NS, Konstantinopoulos PA, Mirabeau-Beale KL, Rose BS, von Keudell AG, Wo JY. PMID: 25056522.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansPHPublic Health
    108. Validated competing event model for the stage I-II endometrial cancer population. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):888-98. Carmona R, Gulaya S, Murphy JD, Rose BS, Wu J, Noticewala S, McHale MT, Yashar CM, Vaida F, Mell LK. PMID: 24969798; PMCID: PMC8783697.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    109. Maximum tumor diameter and the risk of prostate-specific antigen recurrence after radical prostatectomy. Clin Genitourin Cancer. 2014 Oct; 12(5):e173-9. Rose BS, Chen MH, Zhang D, Hirsch MS, Richie JP, Chang SL, Hegde JV, Loffredo MJ, D'Amico AV. PMID: 24787967.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    110. On lumping, splitting, and the nosology of clinical trial populations and end points. J Clin Oncol. 2014 Apr 01; 32(10):1089-90. Mell LK, Zakeri K, Rose BS. PMID: 24550413.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    111. Clinical practice patterns of lung stereotactic body radiation therapy in the United States: a secondary analysis. Am J Clin Oncol. 2013 Jun; 36(3):269-72. Pan H, Rose BS, Simpson DR, Mell LK, Mundt AJ, Lawson JD. PMID: 22495454; PMCID: PMC3396796.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    112. Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma. J Neurooncol. 2013 Jul; 113(3):467-77. Waters JD, Rose B, Gonda DD, Scanderbeg DJ, Russell M, Alksne JF, Murphy K, Carter BS, Lawson J, Chen CC. PMID: 23673513.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    113. Outcomes for patients with cervical cancer treated with extended-field intensity-modulated radiation therapy and concurrent cisplatin. Int J Gynecol Cancer. 2013 Jan; 23(1):119-25. Jensen LG, Hasselle MD, Rose BS, Nath SK, Hasan Y, Scanderbeg DJ, Yashar CM, Mundt AJ, Mell LK. PMID: 23262521.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    114. Competing event risk stratification may improve the design and efficiency of clinical trials: secondary analysis of SWOG 8794. Contemp Clin Trials. 2013 Jan; 34(1):74-9. Zakeri K, Rose BS, Gulaya S, D'Amico AV, Mell LK. PMID: 23063467; PMCID: PMC3525784.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    115. Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):406-14. Liang Y, Bydder M, Yashar CM, Rose BS, Cornell M, Hoh CK, Lawson JD, Einck J, Saenz C, Fanta P, Mundt AJ, Bydder GM, Mell LK. PMID: 22687195.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    116. Reporting of cause-specific treatment effects in cancer clinical trials with competing risks: a systematic review. Contemp Clin Trials. 2012 Sep; 33(5):920-4. Mell LK, Lau SK, Rose BS, Jeong JH. PMID: 22664646.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    117. Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):e81-6. Simpson DR, Song WY, Moiseenko V, Rose BS, Yashar CM, Mundt AJ, Mell LK. PMID: 22516388.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    118. Correlation between radiation dose to ¹⁸F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):1185-91. Rose BS, Liang Y, Lau SK, Jensen LG, Yashar CM, Hoh CK, Mell LK. PMID: 22270171.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    119. Population-based study of competing mortality in head and neck cancer. J Clin Oncol. 2011 Sep 10; 29(26):3503-9. Rose BS, Jeong JH, Nath SK, Lu SM, Mell LK. PMID: 21844503.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    120. Observed magnetic resonance imaging changes in pediatric patients treated with stereotactic radiosurgery for intracranial tumors. Childs Nerv Syst. 2011 Mar; 27(3):399-406. Nath SK, Carmona R, Rose BS, Simpson DR, Russell M, Lawson JD, Mundt AJ, Murphy KT. PMID: 20927529; PMCID: PMC3042094.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    121. A survey of image-guided radiation therapy use in the United States. Cancer. 2010 Aug 15; 116(16):3953-60. Simpson DR, Lawson JD, Nath SK, Rose BS, Mundt AJ, Mell LK. PMID: 20564090; PMCID: PMC2919592.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    122. Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2011 Aug 01; 80(5):1436-45. Hasselle MD, Rose BS, Kochanski JD, Nath SK, Bafana R, Yashar CM, Hasan Y, Roeske JC, Mundt AJ, Mell LK. PMID: 20708346.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    123. Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional data. Int J Radiat Oncol Biol Phys. 2010 Nov 01; 78(3):912-9. Liang Y, Messer K, Rose BS, Lewis JH, Jiang SB, Yashar CM, Mundt AJ, Mell LK. PMID: 20472344; PMCID: PMC2923677.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    124. Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):800-7. Rose BS, Aydogan B, Liang Y, Yeginer M, Hasselle MD, Dandekar V, Bafana R, Yashar CM, Mundt AJ, Roeske JC, Mell LK. PMID: 20400238; PMCID: PMC2907446.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCellsPHPublic Health
    125. Utilization of advanced imaging technologies for target delineation in radiation oncology. J Am Coll Radiol. 2009 Dec; 6(12):876-83. Simpson DR, Lawson JD, Nath SK, Rose BS, Mundt AJ, Mell LK. PMID: 19945044.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    126. Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010 Oct 01; 78(2):435-41. Nath SK, Sandhu AP, Rose BS, Simpson DR, Nobiensky PD, Wang JZ, Millard F, Kane CJ, Parsons JK, Mundt AJ. PMID: 19939580.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    127. Recent advances in image-guided radiotherapy for head and neck carcinoma. J Oncol. 2009; 2009:752135. Nath SK, Simpson DR, Rose BS, Sandhu AP. PMID: 19644564; PMCID: PMC2717698.
      View in: PubMed   Mentions: 7  
    Brenton's Networks
    Concepts (293)
    Derived automatically from this person's publications.
    _
    Co-Authors (90)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _